カテゴリー： Market Monitor Global, 世界, 医療/バイオ

サル痘治療薬のグローバル市場展望 2023年-2029年：経口剤、注射剤

◆英語タイトル：Monkeypox Treatment Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23DC12400）◆商品コード：MMG23DC12400
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年12月
◆ページ数：61
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のサル痘治療薬市場規模と予測を収録しています。・世界のサル痘治療薬市場：売上、2018年-2023年、2024年-2029年
・世界のサル痘治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のサル痘治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「経口剤」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

サル痘治療薬のグローバル主要企業は、Bavarian Nordic、 Chimerix, Inc.、 CIDIC Company Limited、 Emcure Pharmaceuticals、 Emergent、 Gilead Sciences Inc.、 Hetero Drugs Limited、 Jinan Jinda Pharmaceutical Chemistry Co. Ltd.、 Mylan N.V.、 Olon S.p.A.、 Piramal Pharma Solutions、 SIGA Technologies Inc.、 Sonofi SA、 Teva Pharmaceutical Industries Limitedなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、サル痘治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のサル痘治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界のサル痘治療薬市場：タイプ別市場シェア、2022年
・経口剤、注射剤

世界のサル痘治療薬市場：用途別、2018年-2023年、2024年-2029年
世界のサル痘治療薬市場：用途別市場シェア、2022年
・病院薬局、オンライン薬局、小売薬局

世界のサル痘治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界のサル痘治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるサル痘治療薬のグローバル売上、2018年-2023年
・主要企業におけるサル痘治療薬のグローバル売上シェア、2022年
・主要企業におけるサル痘治療薬のグローバル販売量、2018年-2023年
・主要企業におけるサル痘治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Bavarian Nordic、 Chimerix, Inc.、 CIDIC Company Limited、 Emcure Pharmaceuticals、 Emergent、 Gilead Sciences Inc.、 Hetero Drugs Limited、 Jinan Jinda Pharmaceutical Chemistry Co. Ltd.、 Mylan N.V.、 Olon S.p.A.、 Piramal Pharma Solutions、 SIGA Technologies Inc.、 Sonofi SA、 Teva Pharmaceutical Industries Limited

*************************************************************

・調査・分析レポートの概要
サル痘治療薬市場の定義
市場セグメント
世界のサル痘治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のサル痘治療薬市場規模
世界のサル痘治療薬市場規模：2022年 VS 2029年
世界のサル痘治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのサル痘治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のサル痘治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：経口剤、注射剤
サル痘治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院薬局、オンライン薬局、小売薬局
サル痘治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別サル痘治療薬市場規模 2022年と2029年
地域別サル痘治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Bavarian Nordic、 Chimerix, Inc.、 CIDIC Company Limited、 Emcure Pharmaceuticals、 Emergent、 Gilead Sciences Inc.、 Hetero Drugs Limited、 Jinan Jinda Pharmaceutical Chemistry Co. Ltd.、 Mylan N.V.、 Olon S.p.A.、 Piramal Pharma Solutions、 SIGA Technologies Inc.、 Sonofi SA、 Teva Pharmaceutical Industries Limited
...

This research report provides a comprehensive analysis of the Monkeypox Treatment market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Monkeypox Treatment market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Monkeypox Treatment, challenges faced by the industry, and potential opportunities for market players.
The global Monkeypox Treatment market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Monkeypox Treatment market presents opportunities for various stakeholders, including Hospital Pharmacy, Online Pharmacy. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Monkeypox Treatment market. Additionally, the growing consumer demand present avenues for market expansion.
The global Monkeypox Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Monkeypox Treatment market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Monkeypox Treatment market.
Market Overview: The report provides a comprehensive overview of the Monkeypox Treatment market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Oral, Injectable), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Monkeypox Treatment market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Monkeypox Treatment market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Monkeypox Treatment market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Monkeypox Treatment market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Monkeypox Treatment market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Monkeypox Treatment market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Monkeypox Treatment, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Monkeypox Treatment market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Monkeypox Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Oral
Injectable
Market segment by Application
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Global Monkeypox Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Bavarian Nordic
Chimerix, Inc.
CIDIC Company Limited
Emcure Pharmaceuticals
Emergent
Gilead Sciences Inc.
Hetero Drugs Limited
Jinan Jinda Pharmaceutical Chemistry Co. Ltd.
Mylan N.V.
Olon S.p.A.
Piramal Pharma Solutions
SIGA Technologies Inc.
Sonofi SA
Teva Pharmaceutical Industries Limited
Outline of Major Chapters:
Chapter 1: Introduces the definition of Monkeypox Treatment, market overview.
Chapter 2: Global Monkeypox Treatment market size in revenue.
Chapter 3: Detailed analysis of Monkeypox Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Monkeypox Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Monkeypox Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Monkeypox Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Monkeypox Treatment Overall Market Size
2.1 Global Monkeypox Treatment Market Size: 2022 VS 2029
2.2 Global Monkeypox Treatment Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Monkeypox Treatment Players in Global Market
3.2 Top Global Monkeypox Treatment Companies Ranked by Revenue
3.3 Global Monkeypox Treatment Revenue by Companies
3.4 Top 3 and Top 5 Monkeypox Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Monkeypox Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Monkeypox Treatment Players in Global Market
3.6.1 List of Global Tier 1 Monkeypox Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Monkeypox Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Monkeypox Treatment Market Size Markets, 2022 & 2029
4.1.2 Oral
4.1.3 Injectable
4.2 By Type – Global Monkeypox Treatment Revenue & Forecasts
4.2.1 By Type – Global Monkeypox Treatment Revenue, 2018-2023
4.2.2 By Type – Global Monkeypox Treatment Revenue, 2024-2029
4.2.3 By Type – Global Monkeypox Treatment Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Monkeypox Treatment Market Size, 2022 & 2029
5.1.2 Hospital Pharmacy
5.1.3 Online Pharmacy
5.1.4 Retail Pharmacy
5.2 By Application – Global Monkeypox Treatment Revenue & Forecasts
5.2.1 By Application – Global Monkeypox Treatment Revenue, 2018-2023
5.2.2 By Application – Global Monkeypox Treatment Revenue, 2024-2029
5.2.3 By Application – Global Monkeypox Treatment Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Monkeypox Treatment Market Size, 2022 & 2029
6.2 By Region – Global Monkeypox Treatment Revenue & Forecasts
6.2.1 By Region – Global Monkeypox Treatment Revenue, 2018-2023
6.2.2 By Region – Global Monkeypox Treatment Revenue, 2024-2029
6.2.3 By Region – Global Monkeypox Treatment Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Monkeypox Treatment Revenue, 2018-2029
6.3.2 US Monkeypox Treatment Market Size, 2018-2029
6.3.3 Canada Monkeypox Treatment Market Size, 2018-2029
6.3.4 Mexico Monkeypox Treatment Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Monkeypox Treatment Revenue, 2018-2029
6.4.2 Germany Monkeypox Treatment Market Size, 2018-2029
6.4.3 France Monkeypox Treatment Market Size, 2018-2029
6.4.4 U.K. Monkeypox Treatment Market Size, 2018-2029
6.4.5 Italy Monkeypox Treatment Market Size, 2018-2029
6.4.6 Russia Monkeypox Treatment Market Size, 2018-2029
6.4.7 Nordic Countries Monkeypox Treatment Market Size, 2018-2029
6.4.8 Benelux Monkeypox Treatment Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Monkeypox Treatment Revenue, 2018-2029
6.5.2 China Monkeypox Treatment Market Size, 2018-2029
6.5.3 Japan Monkeypox Treatment Market Size, 2018-2029
6.5.4 South Korea Monkeypox Treatment Market Size, 2018-2029
6.5.5 Southeast Asia Monkeypox Treatment Market Size, 2018-2029
6.5.6 India Monkeypox Treatment Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Monkeypox Treatment Revenue, 2018-2029
6.6.2 Brazil Monkeypox Treatment Market Size, 2018-2029
6.6.3 Argentina Monkeypox Treatment Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Monkeypox Treatment Revenue, 2018-2029
6.7.2 Turkey Monkeypox Treatment Market Size, 2018-2029
6.7.3 Israel Monkeypox Treatment Market Size, 2018-2029
6.7.4 Saudi Arabia Monkeypox Treatment Market Size, 2018-2029
6.7.5 UAE Monkeypox Treatment Market Size, 2018-2029
7 Monkeypox Treatment Companies Profiles
7.1 Bavarian Nordic
7.1.1 Bavarian Nordic Company Summary
7.1.2 Bavarian Nordic Business Overview
7.1.3 Bavarian Nordic Monkeypox Treatment Major Product Offerings
7.1.4 Bavarian Nordic Monkeypox Treatment Revenue in Global Market (2018-2023)
7.1.5 Bavarian Nordic Key News & Latest Developments
7.2 Chimerix, Inc.
7.2.1 Chimerix, Inc. Company Summary
7.2.2 Chimerix, Inc. Business Overview
7.2.3 Chimerix, Inc. Monkeypox Treatment Major Product Offerings
7.2.4 Chimerix, Inc. Monkeypox Treatment Revenue in Global Market (2018-2023)
7.2.5 Chimerix, Inc. Key News & Latest Developments
7.3 CIDIC Company Limited
7.3.1 CIDIC Company Limited Company Summary
7.3.2 CIDIC Company Limited Business Overview
7.3.3 CIDIC Company Limited Monkeypox Treatment Major Product Offerings
7.3.4 CIDIC Company Limited Monkeypox Treatment Revenue in Global Market (2018-2023)
7.3.5 CIDIC Company Limited Key News & Latest Developments
7.4 Emcure Pharmaceuticals
7.4.1 Emcure Pharmaceuticals Company Summary
7.4.2 Emcure Pharmaceuticals Business Overview
7.4.3 Emcure Pharmaceuticals Monkeypox Treatment Major Product Offerings
7.4.4 Emcure Pharmaceuticals Monkeypox Treatment Revenue in Global Market (2018-2023)
7.4.5 Emcure Pharmaceuticals Key News & Latest Developments
7.5 Emergent
7.5.1 Emergent Company Summary
7.5.2 Emergent Business Overview
7.5.3 Emergent Monkeypox Treatment Major Product Offerings
7.5.4 Emergent Monkeypox Treatment Revenue in Global Market (2018-2023)
7.5.5 Emergent Key News & Latest Developments
7.6 Gilead Sciences Inc.
7.6.1 Gilead Sciences Inc. Company Summary
7.6.2 Gilead Sciences Inc. Business Overview
7.6.3 Gilead Sciences Inc. Monkeypox Treatment Major Product Offerings
7.6.4 Gilead Sciences Inc. Monkeypox Treatment Revenue in Global Market (2018-2023)
7.6.5 Gilead Sciences Inc. Key News & Latest Developments
7.7 Hetero Drugs Limited
7.7.1 Hetero Drugs Limited Company Summary
7.7.2 Hetero Drugs Limited Business Overview
7.7.3 Hetero Drugs Limited Monkeypox Treatment Major Product Offerings
7.7.4 Hetero Drugs Limited Monkeypox Treatment Revenue in Global Market (2018-2023)
7.7.5 Hetero Drugs Limited Key News & Latest Developments
7.8 Jinan Jinda Pharmaceutical Chemistry Co. Ltd.
7.8.1 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Company Summary
7.8.2 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Business Overview
7.8.3 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Monkeypox Treatment Major Product Offerings
7.8.4 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Monkeypox Treatment Revenue in Global Market (2018-2023)
7.8.5 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Key News & Latest Developments
7.9 Mylan N.V.
7.9.1 Mylan N.V. Company Summary
7.9.2 Mylan N.V. Business Overview
7.9.3 Mylan N.V. Monkeypox Treatment Major Product Offerings
7.9.4 Mylan N.V. Monkeypox Treatment Revenue in Global Market (2018-2023)
7.9.5 Mylan N.V. Key News & Latest Developments
7.10 Olon S.p.A.
7.10.1 Olon S.p.A. Company Summary
7.10.2 Olon S.p.A. Business Overview
7.10.3 Olon S.p.A. Monkeypox Treatment Major Product Offerings
7.10.4 Olon S.p.A. Monkeypox Treatment Revenue in Global Market (2018-2023)
7.10.5 Olon S.p.A. Key News & Latest Developments
7.11 Piramal Pharma Solutions
7.11.1 Piramal Pharma Solutions Company Summary
7.11.2 Piramal Pharma Solutions Business Overview
7.11.3 Piramal Pharma Solutions Monkeypox Treatment Major Product Offerings
7.11.4 Piramal Pharma Solutions Monkeypox Treatment Revenue in Global Market (2018-2023)
7.11.5 Piramal Pharma Solutions Key News & Latest Developments
7.12 SIGA Technologies Inc.
7.12.1 SIGA Technologies Inc. Company Summary
7.12.2 SIGA Technologies Inc. Business Overview
7.12.3 SIGA Technologies Inc. Monkeypox Treatment Major Product Offerings
7.12.4 SIGA Technologies Inc. Monkeypox Treatment Revenue in Global Market (2018-2023)
7.12.5 SIGA Technologies Inc. Key News & Latest Developments
7.13 Sonofi SA
7.13.1 Sonofi SA Company Summary
7.13.2 Sonofi SA Business Overview
7.13.3 Sonofi SA Monkeypox Treatment Major Product Offerings
7.13.4 Sonofi SA Monkeypox Treatment Revenue in Global Market (2018-2023)
7.13.5 Sonofi SA Key News & Latest Developments
7.14 Teva Pharmaceutical Industries Limited
7.14.1 Teva Pharmaceutical Industries Limited Company Summary
7.14.2 Teva Pharmaceutical Industries Limited Business Overview
7.14.3 Teva Pharmaceutical Industries Limited Monkeypox Treatment Major Product Offerings
7.14.4 Teva Pharmaceutical Industries Limited Monkeypox Treatment Revenue in Global Market (2018-2023)
7.14.5 Teva Pharmaceutical Industries Limited Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Monkeypox Treatment Market Opportunities & Trends in Global Market
Table 2. Monkeypox Treatment Market Drivers in Global Market
Table 3. Monkeypox Treatment Market Restraints in Global Market
Table 4. Key Players of Monkeypox Treatment in Global Market
Table 5. Top Monkeypox Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Monkeypox Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Monkeypox Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Monkeypox Treatment Product Type
Table 9. List of Global Tier 1 Monkeypox Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Monkeypox Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Monkeypox Treatment Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Monkeypox Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Monkeypox Treatment Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Monkeypox Treatment Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Monkeypox Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Monkeypox Treatment Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Monkeypox Treatment Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Monkeypox Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Monkeypox Treatment Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Monkeypox Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Monkeypox Treatment Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Monkeypox Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Monkeypox Treatment Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Monkeypox Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Monkeypox Treatment Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Monkeypox Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Monkeypox Treatment Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Monkeypox Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Monkeypox Treatment Revenue, (US$, Mn), 2024-2029
Table 30. Bavarian Nordic Company Summary
Table 31. Bavarian Nordic Monkeypox Treatment Product Offerings
Table 32. Bavarian Nordic Monkeypox Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Bavarian Nordic Key News & Latest Developments
Table 34. Chimerix, Inc. Company Summary
Table 35. Chimerix, Inc. Monkeypox Treatment Product Offerings
Table 36. Chimerix, Inc. Monkeypox Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. Chimerix, Inc. Key News & Latest Developments
Table 38. CIDIC Company Limited Company Summary
Table 39. CIDIC Company Limited Monkeypox Treatment Product Offerings
Table 40. CIDIC Company Limited Monkeypox Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. CIDIC Company Limited Key News & Latest Developments
Table 42. Emcure Pharmaceuticals Company Summary
Table 43. Emcure Pharmaceuticals Monkeypox Treatment Product Offerings
Table 44. Emcure Pharmaceuticals Monkeypox Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Emcure Pharmaceuticals Key News & Latest Developments
Table 46. Emergent Company Summary
Table 47. Emergent Monkeypox Treatment Product Offerings
Table 48. Emergent Monkeypox Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Emergent Key News & Latest Developments
Table 50. Gilead Sciences Inc. Company Summary
Table 51. Gilead Sciences Inc. Monkeypox Treatment Product Offerings
Table 52. Gilead Sciences Inc. Monkeypox Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. Gilead Sciences Inc. Key News & Latest Developments
Table 54. Hetero Drugs Limited Company Summary
Table 55. Hetero Drugs Limited Monkeypox Treatment Product Offerings
Table 56. Hetero Drugs Limited Monkeypox Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. Hetero Drugs Limited Key News & Latest Developments
Table 58. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Company Summary
Table 59. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Monkeypox Treatment Product Offerings
Table 60. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Monkeypox Treatment Revenue (US$, Mn) & (2018-2023)
Table 61. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Key News & Latest Developments
Table 62. Mylan N.V. Company Summary
Table 63. Mylan N.V. Monkeypox Treatment Product Offerings
Table 64. Mylan N.V. Monkeypox Treatment Revenue (US$, Mn) & (2018-2023)
Table 65. Mylan N.V. Key News & Latest Developments
Table 66. Olon S.p.A. Company Summary
Table 67. Olon S.p.A. Monkeypox Treatment Product Offerings
Table 68. Olon S.p.A. Monkeypox Treatment Revenue (US$, Mn) & (2018-2023)
Table 69. Olon S.p.A. Key News & Latest Developments
Table 70. Piramal Pharma Solutions Company Summary
Table 71. Piramal Pharma Solutions Monkeypox Treatment Product Offerings
Table 72. Piramal Pharma Solutions Monkeypox Treatment Revenue (US$, Mn) & (2018-2023)
Table 73. Piramal Pharma Solutions Key News & Latest Developments
Table 74. SIGA Technologies Inc. Company Summary
Table 75. SIGA Technologies Inc. Monkeypox Treatment Product Offerings
Table 76. SIGA Technologies Inc. Monkeypox Treatment Revenue (US$, Mn) & (2018-2023)
Table 77. SIGA Technologies Inc. Key News & Latest Developments
Table 78. Sonofi SA Company Summary
Table 79. Sonofi SA Monkeypox Treatment Product Offerings
Table 80. Sonofi SA Monkeypox Treatment Revenue (US$, Mn) & (2018-2023)
Table 81. Sonofi SA Key News & Latest Developments
Table 82. Teva Pharmaceutical Industries Limited Company Summary
Table 83. Teva Pharmaceutical Industries Limited Monkeypox Treatment Product Offerings
Table 84. Teva Pharmaceutical Industries Limited Monkeypox Treatment Revenue (US$, Mn) & (2018-2023)
Table 85. Teva Pharmaceutical Industries Limited Key News & Latest Developments
List of Figures
Figure 1. Monkeypox Treatment Segment by Type in 2022
Figure 2. Monkeypox Treatment Segment by Application in 2022
Figure 3. Global Monkeypox Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Monkeypox Treatment Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Monkeypox Treatment Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Monkeypox Treatment Revenue in 2022
Figure 8. By Type - Global Monkeypox Treatment Revenue Market Share, 2018-2029
Figure 9. By Application - Global Monkeypox Treatment Revenue Market Share, 2018-2029
Figure 10. By Type - Global Monkeypox Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Monkeypox Treatment Revenue Market Share, 2018-2029
Figure 12. By Application - Global Monkeypox Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Monkeypox Treatment Revenue Market Share, 2018-2029
Figure 14. By Region - Global Monkeypox Treatment Revenue Market Share, 2018-2029
Figure 15. By Country - North America Monkeypox Treatment Revenue Market Share, 2018-2029
Figure 16. US Monkeypox Treatment Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Monkeypox Treatment Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Monkeypox Treatment Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Monkeypox Treatment Revenue Market Share, 2018-2029
Figure 20. Germany Monkeypox Treatment Revenue, (US$, Mn), 2018-2029
Figure 21. France Monkeypox Treatment Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Monkeypox Treatment Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Monkeypox Treatment Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Monkeypox Treatment Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Monkeypox Treatment Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Monkeypox Treatment Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Monkeypox Treatment Revenue Market Share, 2018-2029
Figure 28. China Monkeypox Treatment Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Monkeypox Treatment Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Monkeypox Treatment Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Monkeypox Treatment Revenue, (US$, Mn), 2018-2029
Figure 32. India Monkeypox Treatment Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Monkeypox Treatment Revenue Market Share, 2018-2029
Figure 34. Brazil Monkeypox Treatment Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Monkeypox Treatment Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Monkeypox Treatment Revenue Market Share, 2018-2029
Figure 37. Turkey Monkeypox Treatment Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Monkeypox Treatment Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Monkeypox Treatment Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Monkeypox Treatment Revenue, (US$, Mn), 2018-2029
Figure 41. Bavarian Nordic Monkeypox Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Chimerix, Inc. Monkeypox Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. CIDIC Company Limited Monkeypox Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Emcure Pharmaceuticals Monkeypox Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Emergent Monkeypox Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Gilead Sciences Inc. Monkeypox Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Hetero Drugs Limited Monkeypox Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Monkeypox Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Mylan N.V. Monkeypox Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Olon S.p.A. Monkeypox Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Piramal Pharma Solutions Monkeypox Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. SIGA Technologies Inc. Monkeypox Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Sonofi SA Monkeypox Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Teva Pharmaceutical Industries Limited Monkeypox Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ サル痘治療薬のグローバル市場展望 2023年-2029年：経口剤、注射剤(Monkeypox Treatment Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 月経困難症用治療器具のグローバル市場展望 2023年-2029年：一般輝度、高輝度、超高輝度
  • 6次元治療ベッドのグローバル市場展望 2023年-2029年：ヘッドトリートメント、全身療法、その他
  • ヘイウェル症候群治療のグローバル市場展望 2023年-2029年：分子遺伝学的検査、皮膚生検、出生前診断
  • 下水処理剤のグローバル市場展望 2023年-2029年：化学薬品、生物細菌
  • 慢性痛風治療薬のグローバル市場展望 2023年-2029年：錠剤、カプセル、その他